Rafoxanide
![]() | |
| Names | |
|---|---|
| IUPAC name
N-[3-Chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide | |
| Other names
Rafoxanid, raphoxanide | |
| Identifiers | |
| 22662-39-1 | |
| 3D model (Jmol) | Interactive image |
| ChEMBL | ChEMBL287542 |
| ChemSpider | 29191 |
| ECHA InfoCard | 100.041.029 |
| EC Number | 245-148-9 |
| KEGG | D05693 |
| MeSH | D011888 |
| PubChem | 31475 |
| UNII | 22F4FLA7DH |
| |
| |
| Properties | |
| C19H11Cl2I2NO3 | |
| Molar mass | 626.01 g/mol |
| Appearance | Slight yellowish-brown injectable solution and white oral solution |
| In oily solutes | |
| Pharmacology | |
| QP52AG05 (WHO) | |
| Hazards | |
| Main hazards | Has low safety index (6 times as normal dose) |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
Rafoxanide is a salicylanilide used as an anthelmintic.
This article is issued from Wikipedia - version of the 10/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
